Three times larger than the old building, Stratophase’s new facility has been fitted with offices, meeting rooms and high tech laboratory space, and has room for expansion.
Recently there has been increased interest in the firm's optical microchip sensor technology, SpectroSens, which measures chemical processes and detects biological targets and is being developed for a number of applications in industrial process measurement and biodetection.
The new facility will allow the company to respond more easily to different application requirements. The facilities for implementing and testing new optical measurement techniques on its sensor chips, as well as the systems required to use these chips, have been expanded.
New high-tech lab space includes a dedicated Category 2 Biological Containment Laboratory and a Customer Applications Laboratory. The labs allow Stratophase to functionalise immunoassays on sensor chips for biodetection applications, as well as test monitoring systems for industrial processing applications such as biorefining and the production of biofuels, pharmaceuticals and fine chemicals.
‘Over the last few years, Stratophase has been successfully applying its platform sensing technology in a range of markets,’ said Richard Williams, ceo of Stratophase. ‘Our new facilities give us the infrastructure required to develop core IP, as well as space for the application and product development activities required to service nearer-term customer requirements.’
